by European Public Health Alliance | Nov 14, 2020 | Opinion
Pharmaceutical policies and access to medicines top the policy agenda especially as the COVID19 challenges bring issues such as transparency in pharma, affordability of therapeutics, role of public support in biomedical innovation to the forefront. It is now more...
by European Public Health Alliance | Nov 14, 2020 | Opinion, Statements
Persistent disparities between Roma and non-Roma are observed in EU Member States and Candidate countries regardless of the social and economic situation within the countries. Inequalities in employment, access to decent housing, quality education and healthcare, but...
by European Public Health Alliance | Nov 14, 2020 | Opinion
Guest article | Lydie Meheus PhD, Managing Director, Belgian Anticancer FundCancer patients want to have access to the best available treatment and they want it fast, as in many cases they expect it to be lifesaving.Unfortunately, the current system to bring a new...
by European Public Health Alliance | Nov 14, 2020 | Consultation Responses, Opinion
We have come a long way in a short period of time since the adoption of the groundbreaking June 2016 Council Conclusions on pharmaceuticals. The conclusions were a milestone for the access to medicines debate as they signaled the political acknowledgment of the series...
by European Public Health Alliance | Nov 14, 2020 | Opinion
The European environment – State and Outlook 2020 from the European Environment Agency warns that “Europe’s environment is at a tipping point.” The systemic changes in ecological conditions will have far-reaching effects on human health and well-being,...
by European Public Health Alliance | Nov 8, 2020 | Opinion
The global prevalence of obesity in adults and children has increased dramatically over the past decade, making obesity prevention policies into a priority for many governments and intergovernmental agencies. To determine the cost, equity and acceptability of three...
